Reduced versus maximum tolerated methotrexate dose concomitant with adalimumab in patients with rheumatoid arthritis (MIRACLE): a randomised, open-label, non-inferiority trial

H. Tamai, Kei Ikeda, Toshiaki Miyamoto, Hiroaki Taguchi, Chang‐Fu Kuo, Kichul Shin, Shintaro Hirata, Yutaka Okano, Shinji Sato, Hidekata Yasuoka, Masataka Kuwana, Tomonori Ishii, Hideto Kameda, Toshihisa Kojima, Takehiro Taninaga, Masahiko Mori, Hideaki Miyagishi, Yasunori Sato, Wen‐Chan Tsai, Tsutomu Takeuchi, Yuko Kaneko, Keisuke Izumi, Yasushi Kondo, Keiko Yoshimoto, Takahisa Gono, Sung‐Hwan Park, Han Joo Baek, Yun Jong Lee, In Ah Choi, Jinhyun Kim, Ping‐Ning Hsu, Chun-Ming Huan, Meng‐Yu Weng, Wan‐Yu Sung, Tien‐Tsai Cheng